Insulet CEO Patrick Sullivan elected chairman of the board
Insulet Corporation announced changes to the responsibilities of key members of its board of directors and management team. Patrick Sullivan, President and Chief Executive Officer since September 2014, has been elected Chairman of the Board. He will continue to serve as Chief Executive Officer. Jessica Hopfield, Director since July 2015, has been appointed Lead Independent Director of the Board. Shacey Petrovic, President, Diabetes Products since February 2016, after joining the Company as Chief Commercial Officer in February 2015, has been promoted to President and Chief Operating Officer. Daniel Levangie, President, Drug Delivery, has informed the Company he will retire at the end of 2016. Ms. Petrovic will assume Mr. Levangie's responsibilities and Mr. Levangie will continue with the Company through the end of the year to assist with an effective transition. He will then remain available to the Company in a consulting role.